16th Annual Meeting on Influenza

We are a globally recognized and trusted organization to provide unique scientific and business services through our Journals and we are expanding the functionality of our International conferences. We are an international collaborative venture incorporating academicians, researchers, scholars and business entrepreneurs to exchange information from past two decades. End Quote

(1888PressRelease) September 26, 2017 - Influenza 2018 will attract a large group of scientists and researchers round the globe. We extend a warm welcome to the distinguished Nobel laureates, Researchers, members from Public Health, Clinicians, Professors, delegates from Associations, Societies, Pharmacy Industries, Biotech companies to attend International conference on Influenza during March 28-29, 2018 held at Orlando, USA hosted by Allied Academies through the theme “Scrutinizing the Advancing Research”, conference will explore the Influenza research and various ailments through invited plenary lectures, symposia, workshops, invited sessions, oral and poster sessions, B2B meetings.

Influenza is a highly communicable disease and typically has the most severe impact on children and the elderly. Influenza viruses are considered as a major cause of morbidity and mortality worldwide. The global influenza market reached $5.1 billion in 2015. This market is expected to increase from $5.4 billion in 2016 to $6.4 billion in 2021 at a compound annual growth rate (CAGR) of 3.6% for 2016-2021. Currently, North America held largest market share due to higher rate of in-vitro diagnostics availability and technologically advanced medical devices which are primarily driving the market growth in North America. Asia Pacific is expected to show highest growth rate during forecast period due to the rising healthcare awareness, higher number of targeted population and increasing demand for advanced diagnostic technologies, fuelling the market growth during forecast period. The influenza diagnostics market is observed to be highly competitive and comprises large number of players. However, the market is currently dominated by few players such as Alere, Becton, Dickinson and Company, Meridian Bioscience, Inc., Princeton BioMedtech corp., Quidel Corporation, Roche Diagnostics, SA Scientific, Inc., Sekisui Diagnostics, Thermo Fisher Scientific and other.

This two-day Conference will address key issues concerning Influenza strains, pandemics, epidemics and its impacts in the broader context of Epidemiology, Pathology, Virology, Clinical microbiology and Immunology. The Conference focuses on moving from present knowledge to future scope and advancements. We cordially invite you to contribute through submission of your high quality research abstracts, posters and e-posters for presenting at the conference and help to configure the gathering.

We are a globally recognized and trusted organization to provide unique scientific and business services through our Journals and we are expanding the functionality of our International conferences.

###

space

Other Related Press Releases

16th Annual Meeting on Influenza by Allied Academies
Automotive Sector Sees a Hike in Jobs during September by Recruitive